Linea Aspesi
Human Resources Officer bei EDITAS MEDICINE, INC.
Profil
Linea Aspesi is currently the Chief People Officer & Executive Vice President at Editas Medicine, Inc. Prior to this, Linea held the position of Chief Human Resources Officer & Senior VP at Red Robin Gourmet Burgers, Inc. Linea also served as the Chief Human Resources Officer at Forma Therapeutics Holdings, Inc. and Saniona AB.
Additionally, Linea was the VP & Head of Human Resources & Office Management at Sobi,.
Inc. Linea completed their undergraduate degree at the University of Massachusetts.
Aktive Positionen von Linea Aspesi
| Unternehmen | Position | Beginn |
|---|---|---|
| EDITAS MEDICINE, INC. | Human Resources Officer | 01.02.2023 |
Ehemalige bekannte Positionen von Linea Aspesi
| Unternehmen | Position | Ende |
|---|---|---|
| FORMA THERAPEUTICS HOLDINGS, INC. | Human Resources Officer | - |
| Sobi, Inc. | Human Resources Officer | - |
| RED ROBIN GOURMET BURGERS, INC. | Human Resources Officer | - |
| SANA AB | Human Resources Officer | - |
Ausbildung von Linea Aspesi
| University of Massachusetts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| RED ROBIN GOURMET BURGERS, INC. | Consumer Services |
| EDITAS MEDICINE, INC. | Health Technology |
| SANA AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA. | Health Technology |
| Sobi, Inc. |
